Answers are grounded in this paper and cite their sources.
People with schizophrenia often experience considerable difficulties in daily life because of a wide constellation of symptoms associated with the condition. This article examines the pharmaceutical targets that are being investigated to provide greater efficacy and tolerability than the current dopamine‐focussed drugs.
No takes yet. Share an insight, caveat, or question.
Mark Greener (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: